REGENXBIO Inc., a biotechnology company specializing in gene therapy, announced it will participate in the Stifel 2026 Healthcare Conference on November 11, 2026. The company will hold a fireside chat at 9:20 a.m. ET in New York, which will be available via live webcast on their website. REGENXBIO is advancing late-stage gene therapy treatments for rare and retinal diseases, collaborating with partners like Nippon Shinyaku and AbbVie. This event provides investors an opportunity to learn more about REGENXBIO's innovative pipeline and future prospects.
REGENXBIO's upcoming participation in the Stifel 2026 Healthcare Conference provides context for healthcare sector activity. For readers following healthcare stocks, here is Pluang's market snapshot as of Nov 03, 2026 19:02 WIB: Out of 150 priced US healthcare stocks, 74 rose and 69 fell. Notable movers include NUWE (Nuwellis Inc) at USD 4.90 with a 1-day change of -5.41% and a typical hold time of 30 days, AHCO (AdaptHealth Corp) at USD 6.20 with a 1-day change of +4.91% and 90% buy order activity, and NUVB (Nuvation Bio Inc. Class A Common Stock) at USD 4.81 with a 1-day change of +4.79% and a typical hold time of 18 days.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
